The San Francisco-based startup, which closed a $5 million Series A round in 2017, aims to develop nutritionally enhanced food and feed crops.
The collaborators will grant the licenses to any entities wanting to use the technology for commercial agricultural research and product development.
Agricultural companies are thinking about how to get consumers comfortable with gene-edited crops, the Wall Street Journal says.
DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.
The company said its acquisition of DuPont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers.
DuPont Pioneer has entered into a collaboration to apply CRISPR genome editing to the development of crop varieties for farmers in developing countries.
DuPont Pioneer researchers used a CRISPR genome editing approach to develop corn that appears to be more drought tolerant.
The firms also renewed distribution agreements for DuPont's BAX System Q7 food safety testing platform in Canada, Australia and New Zealand.
The in vitro assay enabled the scientists to take an uncharacterized Cas9 variant from Brevibacillus laterosporus and edit maize cells with it.
DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.